arXiv paper· medical imaging AI (computational radiology)· empirical study (retrospective matched cohort analysis)

Foundation model embeddings capture pre-diagnostic changes on screening mammograms

Kalina P. Slavkova, Eric Brattain, Aditya Gowd, Akash Pattnaik, Jean-Benoit Delbrouck, Matthew Morgan, Julie Bauml, Javid Abderezaei, et al.

cs.CV · cs.LG

Quick verdict

Claims mammogram foundation-model embeddings drift toward a cancer direction 1-2y before biopsy; matched analysis is rigorous but data are proprietary.

Summary

The study asks whether frozen foundation-model embeddings of screening mammograms change measurably in the years before a breast-cancer diagnosis, without any task-specific cancer classifier. Using 1,773 matched case-control pairs (785 malignant, 988 biopsy-negative), each with at least two annual priors, the authors compute per-breast "embedding velocity" along a data-derived cancer direction built leave-one-out, after longitudinal ComBat manufacturer harmonization and L2 normalization. Four 2D encoders spanning the pretraining spectrum run an identical pipeline: Mammo-CLIP, HOPPR, MedImageInsight (MII), and BiomedCLIP. In Holm-corrected paired Wilcoxon tests, malignant cases drift faster than controls at intervals 1-2 before biopsy for the three clinically grounded models — at interval 1, Holm p = 1.3e-51 (rank-biserial r = +0.63) for MII, 1.5e-11 (r = +0.28) for Mammo-CLIP, 5.0e-6 for HOPPR — with a broadly similar within-patient contralateral pattern. Under modality matching, HOPPR loses significance entirely and BiomedCLIP's signal collapses from p = 7.2e-5 to 0.19, exposing it as acquisition-driven (synthetic-2D index exams). Race, calendar-year, and DCIS/invasive subgroup analyses hold. Main limitations: a single proprietary data vault, an in-distribution but closed HOPPR model, and no external validation or code release.

Review complete

Assessment at a glance

medical imaging AI (computational radiology)

4

risk flags identified

● high 0

● medium 2

● low 2

Reproducibility readinesslow
Code & data availablenot stated
Review confidencemedium
AI text signal0/20 passages flagged
Deep research viable

4 strengths · 4 weaknesses · 5 author questions

AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.

Levels reflect verification complexity — not a quality score. Evolve never rates your paper.

Key claims under review

  • Screening-mammogram embeddings from clinically grounded foundation models drift faster along a data-derived cancer direction in women later biopsied for cancer than in matched controls, with the signal concentrated in the two screening intervals before biopsy.
  • The velocity signal survives modality-matched, race-stratified, calendar-year-adjusted, and within-patient contralateral analyses, and holds for both invasive carcinoma and DCIS subtypes.
  • BiomedCLIP's apparent velocity signal is acquisition-driven (synthetic-2D index exams) and disappears under modality matching, implying pretraining exposure to clinical images is necessary to encode pre-diagnostic change.
  • Pretraining domain does not monotonically predict signal quality: the general-radiological MedImageInsight yields the strongest, least acquisition-sensitive signal, while in-distribution HOPPR is weakest.

Strengths

  • Multi-design triangulation of one hypothesis

    The same signal is tested between-patient on matched pairs (§4.3, Table 2), within-patient on biopsied-vs-contralateral breasts with a seeded-random null control arm (§4.4, Tables 4-5), and via a linear mixed model with time×group interaction (§3.6.3, Table S12); the patterns cohere, which is hard to produce by a single artifact.

  • Explicit confound forensics on modality

    §4.1.1 documents that 63/785 malignant patients switch from FFDM to tomosynthesis-derived imaging exactly at the index exam, explains why modality cannot be ComBat-harmonized (disease-confounded; Table S2), and stratifies instead. BiomedCLIP then works as a falsification arm: its interval-1 signal (p = 7.2e-5) collapses to p = 0.19 under modality matching, cleanly demonstrating an acquisition artifact.

  • Effect sizes and correction discipline alongside p-values

  • Leave-one-out cancer direction avoids label circularity

Weaknesses

  • Irreproducible core: closed data and a closed model

  • Residual acquisition confound sits exactly at the headline interval

  • HOPPR's in-distribution training on the same data source

  • Statistical asymmetries at the margins

Full Review Report

$1.99 · one-time

Unlock the complete preliminary analysis Evolve produced for this paper.

Report preview

Scope & Claims

The paper asks a temporal-representation question: do frozen foundation-model embeddings of screening mammograms encode subclinical change in the years before biopsy, without any cancer-classification fine-tuning? On 1,773 matched case-control pairs (785 malignant, 988 biopsy-negative; §2.2), each with ≥2 annual priors spaced 335–425 days (§2.1), the authors measure per-breast "embedding velocity" — signed displacement per year along a data-derived cancer direction — across four 2D encoders spanning the pretraining spectrum: Mammo-CLIP (mammography CLIP), HOPPR (in-distribution, proprietary), MedImageInsight (MII, general radiological), and BiomedCLIP (literature figures). The claims are: (i) a pre-diagnostic velocity signal in the two intervals before biopsy for clinically grounded models; (ii) robustness across modality, race, calendar year, and both between- and within-patient designs; (iii) BiomedCLIP's signal is acquisition-driven; (iv) pretraining domain does not monotonically predict signal quality, with MII strongest. Claims are scoped honestly — the abstract and Discussion avoid predictive-test language and defer clinical utility to prospective validation.

The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.

  • All 4 strengths & 4 weaknesses, analyzed in detail
  • 4 risk flags with severity, section & reviewer questions
  • Methods & statistical evidence assessment
  • 5 questions a peer reviewer would ask
  • Full six-dimension evaluation report & recommendations

One-time purchase · this paper only

One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.

Frequently asked questions

What is 'embedding velocity' in this paper?

It is the rate (per year) at which a woman's mammogram embedding, produced by a frozen AI foundation model, moves toward a 'cancer direction' — a vector in embedding space computed from the malignant-vs-control centroid difference at the index exam, built leave-one-out so a patient's own label never defines the direction her earlier exams are scored against.

Does this mean AI can detect breast cancer two years before mammograms show it?

No. The study is retrospective: it shows a statistical drift in frozen model embeddings before biopsy in matched case-control pairs, not a validated early-detection test. The authors explicitly state that clinical value requires a prospective study flagging patients by embedding velocity and testing subsequent biopsy outcomes.

Which foundation model worked best and why?

MedImageInsight, a general medical-imaging model, gave the strongest signal (interval-1 Holm p = 1.3e-51, rank-biserial r = +0.63, essentially unchanged at r = +0.61 under modality matching). The authors attribute its advantage to smaller per-patient variance rather than larger group separation, and stress their mechanistic explanation is speculative.

Why did BiomedCLIP fail in this analysis?

Its full-cohort velocity signal (interval-1 p = 7.2e-5) vanished under modality matching (p = 0.19). Because BiomedCLIP was trained on figure-caption pairs from biomedical literature rather than clinical images, its apparent temporal signal tracked the synthetic-2D acquisition format of the index exams instead of tissue biology.

About this review

This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.

  • Text extraction is heavily glyph-corrupted (Greek/math symbols mangled) and most table p-values render as unreadable placeholder strings; only p-values quoted verbatim in prose were relied upon.
  • Figures (Figs. 1-5, S1-S3) could not be analyzed from the extracted text.
  • Parts of Methods §3.3-3.4 and Results tables are truncated/garbled; some pipeline details (exact LOO construction, velocity units) are inferred from surrounding text.
  • Absence of a code/data availability statement is inferred from the extraction; it may exist in portions not extracted.

Go deeper on this paper

Reproduce ResultsNot feasible for this paper — the core results cannot be re-derived by sandboxed code simulation.

Wrote a paper? Stress-test it before reviewers do.

Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.

Scan your paper
Foundation model embeddings capture pre-diagnostic changes on screening mammograms | Evolve.Pub